Chembio Diagnostics to Participate in Upcoming Investor Conferences

    NEXT STORY
    Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial
    PREV STORY
    SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Seven Medical Societies Join the ACR to Oppose Insurer Policy Limiting Access to In-Office Treatments

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces Additional Data from Positive Phase III Study of RHB-104 in Crohn’s Disease at United European Gastroenterology (UEG) Week 2018

    The presentation highlighted enhanced p-values for previously reported outcomes, including the primary endpoint of ...

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

    LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a ...

    author_avatar
    NASDAQ Market News